Complementary  	Complementary  	 NNP	B-NP
and  	and  	 CC	I-NP
Alternative  	Alternative  	 NNP	I-NP
Medicine  	Medicine  	 NNP	I-NP
( 	( 	 -LRB-	O
CAM 	CAM 	 NNP	B-NP
) 	) 	 -RRB-	O
:  	:  	 :	O
considerations  	considerations  	 NNS	B-NP
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
major  	major  	 JJ	O
depressive  	depressive  	 NNS	O
disorder  	disorder  	 VBP	O
The  	The  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
complementary  	complementary  	 JJ	B-NP
and  	and  	 CC	I-NP
alternative  	alternative  	 JJ	I-NP
medicine  	medicine  	 NN	I-NP
( 	( 	 -LRB-	O
CAM 	CAM 	 NNP	B-NP
)  	)  	 -RRB-	O
has  	has  	 VBZ	O
increased  	increased  	 VBN	O
among  	among  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
psychiatric  	psychiatric  	 JJ	B-NP
disorders 	disorders 	 NNS	I-NP
,  	,  	 ,	O
as  	as  	 IN	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
in  	in  	 IN	O
the  	the  	 DT	O
general  	general  	 JJ	O
population 	population 	 NN	O
,  	,  	 ,	O
over  	over  	 IN	O
recent  	recent  	 JJ	O
decades 	decades 	 NNS	O
.  	.  	 .	O
Psychiatrists 	Psychiatrists 	 NNP	O
,  	,  	 ,	O
therefore 	therefore 	 RB	O
,  	,  	 ,	O
need  	need  	 VBP	O
to  	to  	 TO	O
inquire  	inquire  	 VB	O
about  	about  	 RB	O
and  	and  	 CC	O
discuss  	discuss  	 VB	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
treatments  	treatments  	 NNS	O
with  	with  	 IN	O
patients  	patients  	 NNS	O
and  	and  	 CC	O
offer  	offer  	 VB	O
up-to-date  	up-to-date  	 JJ	O
information  	information  	 NN	O
about  	about  	 IN	O
risks  	risks  	 NNS	O
and  	and  	 CC	O
benefits 	benefits 	 NNS	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
evidence-based  	evidence-based  	 JJ	O
information  	information  	 NN	O
is  	is  	 VBZ	O
limited 	limited 	 VBN	O
.  	.  	 .	O
To  	To  	 TO	O
address  	address  	 VB	O
the  	the  	 DT	O
needs  	needs  	 NNS	O
of  	of  	 IN	O
practicing  	practicing  	 VBG	O
psychiatrists  	psychiatrists  	 NNS	O
and  	and  	 CC	O
the  	the  	 DT	O
public 	public 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
American  	American  	 NNP	O
Psychiatric  	Psychiatric  	 NNP	O
Association  	Association  	 NNP	O
has  	has  	 VBZ	O
set  	set  	 VBN	O
up  	up  	 RP	O
a  	a  	 DT	O
task  	task  	 NN	B-NP
force  	force  	 NN	I-NP
on  	on  	 IN	O
CAM  	CAM  	 NNP	O
to  	to  	 TO	O
review  	review  	 VB	O
the  	the  	 DT	O
evidence  	evidence  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
efficacy  	efficacy  	 NN	O
and  	and  	 CC	O
safety  	safety  	 NN	O
of  	of  	 IN	O
CAM  	CAM  	 NNP	O
treatments  	treatments  	 NNS	O
in  	in  	 IN	O
major  	major  	 JJ	B-NP
depressive  	depressive  	 JJ	I-NP
disorder  	disorder  	 NN	I-NP
( 	( 	 -LRB-	O
MDD 	MDD 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Some  	Some  	 DT	O
CAM  	CAM  	 NNP	O
treatments  	treatments  	 NNS	O
have  	have  	 VBP	O
known  	known  	 VBN	O
general  	general  	 JJ	O
health  	health  	 NN	B-NP
benefits  	benefits  	 NNS	I-NP
but  	but  	 CC	O
currently  	currently  	 RB	O
equivocal  	equivocal  	 JJ	B-NP
evidence  	evidence  	 NN	I-NP
of  	of  	 IN	O
benefit  	benefit  	 NN	O
in  	in  	 IN	O
MDD 	MDD 	 NNP	B-NP
.  	.  	 .	O
Exercise 	Exercise 	 NN	O
,  	,  	 ,	O
folate 	folate 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
omega-3  	omega-3  	 CD	B-NP
fatty  	fatty  	 CD	O
acids  	acids  	 NNS	O
can  	can  	 MD	O
be  	be  	 VB	O
recommended  	recommended  	 VBN	O
to  	to  	 TO	O
most  	most  	 JJS	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
MDD  	MDD  	 NNP	B-NP
for  	for  	 IN	O
their  	their  	 PRP$	O
general  	general  	 JJ	O
health  	health  	 NN	B-NP
benefits 	benefits 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
St  	St  	 NNP	B-NP
John 	John 	 NNP	I-NP
's  	's  	 POS	O
wort  	wort  	 NN	B-NP
and  	and  	 CC	O
S-adenosyl-L-methionine  	S-adenosyl-L-methionine  	 NNP	B-NP
( 	( 	 -LRB-	O
SAM-e 	SAM-e 	 NNP	B-NP
)  	)  	 -RRB-	O
may  	may  	 MD	O
be  	be  	 VB	O
appropriate  	appropriate  	 JJ	O
to  	to  	 TO	O
treat  	treat  	 VB	O
depression  	depression  	 NN	O
in  	in  	 IN	O
some  	some  	 DT	O
patients 	patients 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
all  	all  	 DT	O
instances 	instances 	 NNS	O
,  	,  	 ,	O
use  	use  	 NN	O
of  	of  	 IN	O
CAM  	CAM  	 NNP	O
therapies  	therapies  	 NNS	O
should  	should  	 MD	O
not  	not  	 RB	O
take  	take  	 VB	O
the  	the  	 DT	O
place  	place  	 NN	O
of  	of  	 IN	O
diagnostic  	diagnostic  	 JJ	B-NP
assessment  	assessment  	 NN	I-NP
and  	and  	 CC	O
evaluation  	evaluation  	 NN	O
for  	for  	 IN	O
MDD  	MDD  	 NNP	B-NP
and  	and  	 CC	O
consideration  	consideration  	 NN	B-NP
of  	of  	 IN	O
standard  	standard  	 JJ	O
treatment  	treatment  	 NN	B-NP
use 	use 	 NN	I-NP
.  	.  	 .	O
Patients  	Patients  	 NNS	O
should  	should  	 MD	O
receive  	receive  	 VB	O
advice  	advice  	 NN	B-NP
about  	about  	 IN	O
all  	all  	 DT	O
available  	available  	 JJ	O
treatment  	treatment  	 NN	B-NP
options 	options 	 NNS	I-NP
,  	,  	 ,	O
including  	including  	 VBG	B-NP
risks 	risks 	 NNS	I-NP
,  	,  	 ,	O
benefits 	benefits 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
possible  	possible  	 JJ	O
drug  	drug  	 NN	B-NP
interactions 	interactions 	 NNS	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
full  	full  	 JJ	O
evaluations  	evaluations  	 NNS	O
and  	and  	 CC	O
regular  	regular  	 JJ	B-NP
monitoring 	monitoring 	 NN	I-NP
.  	.  	 .	O
